Our latest article “Classification of Medical Devices and Placing the Same on the Market” by Nihan Bacanak, Zeynep Toma and Selen Toma is published on Mondaq.
Medical Device Regulation (the “MDR“) and In Vitro Diagnostic Medical Device Regulation (the “IVDR“), as adopted by the Turkish Medicine and Medical Devices Authority (“Authority“) are the main pieces of legislation in Turkey in relation to medical devices. With an effort to align with the EU standards, the provisions of MDR and IVDR mostly mirror the provisions of Medical Devices Regulation numbered 2017/475 and In Vitro Diagnostic Medical Devices Regulation numbered 2017/746 of the European Union.
Medical devices are classified in two main categories under the Turkish medical devices legislation: (i) medical devices and (ii) in vitro diagnostic medical devices. There are a number of sub-categories under the MDR such as invasive, non-invasive, custom-made, active, investigational, implantable medical devices. Certain products that may be considered as non-medical per se such as contact lenses, cosmetic implant devices, liposuction equipment, lasers and brain stimulation equipment are also included within the scope of the MDR, and are thus subject to the related medical devices legislation.
Classification. Medical devices are classified on a risk-basis approach under (i) Classes I, IIa, IIb and III for medical devices, and (ii) A, B, C and D for in vitro diagnostic medical devices from the lowest to the highest risk group. The risk classes are determined based on the intended usage purpose of the medical device and the risks that the medical device entails due to its nature and complexity.
You may reach the full of article here.
Share
Related persons
You can contact us for detailed information.



Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
2 March 2026
Use of Health Declarations in Cosmetic Products
A health declaration is any statement or implication that a product or ingredients within its composition confers a benefit on human health…
19 February 2026
Turkish Competition Law Newsletter – 2026 Winter Issue
Welcome to the 2026 Winter edition of the Paksoy Turkish Competition Law Newsletter series.
17 February 2026
The Constitutional Court Confirmed the Competition Authority’s Power to Conduct On-Site Inspections
The Constitutional Court decision dated 6 November 2025 and numbered E. 2023/174, K. 2025/224 (“Constitutional Court Decision”), published…
17 February 2026
Türkiye’s Digital Copyright Bill under parliamentary review: key takeaways for digital platforms and rightsholders
On 10 December 2025, the Digital Copyright Bill (“Bill”) was submitted to the Presidency of the Turkish Parliament.
11 February 2026
New Merger Control Regulation From The Turkish Competition Board: Increased Turnover Thresholds And Special Regulation For Technology Undertakings
With the Communiqué Amending the Communiqué on Mergers and Acquisitions Requiring the Approval of the Competition Board (Communiqué No:…
6 February 2026
Legal Developments Regarding the Cultivation of Cannabis and Cannabis Products
The Regulation on Cannabis Cultivation and Control (“Regulation on Cannabis Cultivation”) and the Regulation on Products Derived from…